Group 1 - The company will hold its third extraordinary general meeting of shareholders on September 3, 2025, at 14:30 [2][4][58] - The voting will be conducted through a combination of on-site and online voting systems provided by the Shanghai Stock Exchange [4][5][58] - Shareholders must register to attend the meeting, with specific documentation required for both corporate and individual shareholders [11][12][14] Group 2 - The company has returned 90 million RMB of idle raised funds to the special account and plans to use 43.5838 million RMB of remaining over-raised funds for permanent working capital [21][20][52] - The total amount of over-raised funds is 285.268 million RMB, with the current proposal representing 15.28% of this total [21][52] - The company has received a no-objection opinion from its sponsor regarding the use of these funds [22][35] Group 3 - The company has previously used idle raised funds temporarily for working capital, with a total of 90 million RMB returned as of August 18, 2025 [21][44] - The company has a history of using over-raised funds for various projects, including the construction of a polystyrene production facility and expansion of flame retardant production [27][48] - The company has committed to not exceeding 30% of the total over-raised funds for permanent working capital within any twelve-month period [31]

Core Viewpoint - Tianfeng Securities has conducted a special review regarding Guangdong Jushi Chemical Co., Ltd.'s return of raised funds and the use of remaining over-raised funds for permanent working capital supplementation, confirming compliance with relevant regulations and the interests of the company and its shareholders [1][7]. Summary by Sections 1. Basic Situation of Raised Funds - Guangdong Jushi Chemical was approved to publicly issue 23,333,334 shares at a price of RMB 36.65 per share, raising a total of RMB 855.1667 million, with a net amount of RMB 775.7297 million after deducting issuance costs of RMB 79.4370 million [1][2]. 2. Return of Temporarily Used Funds - The company temporarily used up to RMB 90 million of idle raised funds for working capital, which was approved by the board and returned to the special account by the date of the review [2][6]. 3. Investment Project Overview - The total investment amount for the projects funded by the raised funds is RMB 490.4617 million, with the net amount of raised funds being RMB 775.7297 million, resulting in a total over-raised amount of RMB 285.2680 million [2][4]. 4. Use of Over-raised Funds - The company plans to use RMB 43.5844 million of the remaining over-raised funds for permanent working capital, which accounts for 15.28% of the total over-raised funds [5][6]. 5. Compliance and Commitments - The company commits that the cumulative use of over-raised funds for permanent working capital will not exceed 30% of the total over-raised funds within any twelve-month period, ensuring that this will not affect the funding needs of investment projects [6][7]. 6. Review Procedures - The proposal for using the remaining over-raised funds for permanent working capital has been approved by the board and is pending submission to the shareholders' meeting for further approval [6][8]. 7. Sponsor's Review Opinion - Tianfeng Securities has no objections to the company's plan to use remaining over-raised funds for permanent working capital, confirming that the necessary review procedures have been followed and that there is no change in the purpose of the raised funds [7][8].

Fundraising Overview - The company raised a total of RMB 855.17 million through its initial public offering, with a net amount of RMB 796.85 million after deducting issuance costs [1][2] - As of June 30, 2025, the remaining balance of the raised funds is RMB 52,004.35 [1][2] Fund Utilization - The company has utilized RMB 389.64 million for project investments and has allocated RMB 180.64 million from project completion surplus funds to supplement working capital [1][2] - The company has also temporarily supplemented working capital with RMB 240 million from idle raised funds, which has been returned to the special account as of August 2, 2023 [5][6] Project Changes - The implementation subject of the "Halogen-free Flame Retardant Expansion Project" has been changed from a subsidiary in Qingyuan to a subsidiary in Chizhou, with a total planned investment of RMB 12.02 million [2][9] - The "Chizhou Polystyrene Production Project" has been transferred to another subsidiary in Anqing, with the investment remaining at RMB 8 million [2][4] Financial Management - The company has invested RMB 121 million of idle raised funds in principal-protected financial products, yielding a total return of RMB 367,000 [7] - The company has also used part of the raised funds for cash management, ensuring that it does not affect the progress of investment projects [7] Economic Benefits - The "Halogen-free Flame Retardant Expansion Project" and "Polystyrene Production Project" are expected to generate significant economic benefits, with projected annual outputs and revenues [10][12] - The company reported that the production capacity utilization rates for these projects are in line with expectations, with the "Polystyrene Production Project" achieving a utilization rate of 58.40% in 2023 [12]

Core Viewpoint - The report provides an overview of the fundraising activities and the utilization of funds by Guangdong Jushi Chemical Co., Ltd., highlighting the total amount raised, expenses incurred, and the current status of the funds as of June 30, 2025 [1][2]. Fundraising Overview - The total amount raised through the initial public offering (IPO) was RMB 855.17 million, with net proceeds amounting to RMB 775.73 million after deducting issuance costs of RMB 79.44 million [2][3]. - The funds were fully deposited into a designated account approved by the board of directors, and a regulatory agreement was signed with the sponsoring institution and the bank [2][3]. Fund Utilization - As of June 30, 2025, the total amount utilized from the raised funds was RMB 796.85 million, with various deductions for underwriting fees, pre-invested funds, and temporary working capital [2][3]. - The company has also temporarily supplemented working capital with idle funds, amounting to RMB 47.58 million, which was returned to the designated account by August 2, 2023 [5][6]. Project Changes - The implementation subject and location for the "Halogen-free Flame Retardant Expansion Project" were changed from a subsidiary in Guangdong to another in Anhui due to local regulatory constraints [3][7]. - The "Poly Styrene Production Project" was also relocated from Anhui to a different site in Anhui, reflecting strategic adjustments based on land availability and logistical considerations [4][7]. Financial Management - The company has engaged in cash management with idle funds, investing a total of RMB 121 million in low-risk financial products, yielding a return of RMB 367,042.51 [5][6]. - The company has also utilized excess funds for permanent working capital supplementation, with a total of RMB 80 million allocated for this purpose [6][7]. Economic Benefits - The projects funded by the raised capital are expected to generate significant economic benefits, although some projects, such as those for working capital and R&D, do not yield direct financial returns [8][12]. - The production capacity and output from the projects have been monitored, with the "Modified Plastic Expansion Project" achieving a production output of 23,358.52 tons in 2023, with a capacity utilization rate of 58.40% [12].

Investment Rating - The report maintains a "Strong Buy" rating for Satellite Chemical, expecting it to outperform the benchmark index by over 20% in the next six months [2][18]. Core Views - Satellite Chemical reported a revenue of 23.46 billion yuan for the first half of 2025, a year-on-year increase of 20.93%, and a net profit attributable to shareholders of 2.744 billion yuan, up 33.44% year-on-year [2]. - The company is expected to benefit from a decline in ethane prices, which may help restore profitability in Q3 2025 [2][8]. - The company is expanding its industrial chain and enhancing its facilities, with significant investments in high-value products [2][8]. Financial Performance Summary - For Q2 2025, the company achieved a revenue of 11.131 billion yuan, with a year-on-year increase of 5.05% but a quarter-on-quarter decrease of 9.72% [2]. - The gross profit margin for Q2 2025 decreased by 2.35 percentage points to 19.33%, and the net profit margin fell by 2.16 percentage points to 10.55% [8]. - The report forecasts revenue growth rates of 10.0%, 10.5%, 9.6%, and 23.0% for the years 2024 to 2027, respectively [4]. Price Target and Valuation - The target price for Satellite Chemical is set at 23.04 yuan, based on a relative valuation method using a 12x PE ratio for 2025 [4][8]. - The current market price is 18.63 yuan, indicating potential upside [4]. Industry Outlook - The report highlights that the ethane supply is returning to normal, which may lead to a more favorable cost structure for the company [8]. - The company is also expected to benefit from the completion of its alpha-olefins project, which has a total investment of 26.6 billion yuan [8].

Core Viewpoint - The company aims to become a world-class chemical new materials technology company, focusing on high-quality development in the C2 and C3 industrial chains, with continuous innovation in functional chemicals, polymer new materials, new energy materials, hydrogen energy, and comprehensive utilization of carbon dioxide [1]. Financial Performance - The company reported a revenue of 23.46 billion yuan for the current reporting period, representing a year-on-year increase of 20.93% compared to 19.40 billion yuan in the same period last year [4]. - The net profit attributable to shareholders reached 2.74 billion yuan, up 33.44% from 2.06 billion yuan in the previous year [4]. - The net profit after deducting non-recurring gains and losses was 2.90 billion yuan, reflecting a 29.61% increase from 2.23 billion yuan [4]. - The net cash flow from operating activities was 5.05 billion yuan, a significant increase of 138.88% from 2.12 billion yuan [4]. - Basic and diluted earnings per share were both 0.81 yuan, marking a 32.79% increase from 0.61 yuan [4]. - The weighted average return on equity was 8.61%, up 0.80% from 7.81% [4]. C2 Sector Development - The company has established a comprehensive development matrix for downstream chemicals of ethylene oxide, with production capacities of 1.82 million tons of ethylene glycol, 500,000 tons of polyether monomers and surfactants, 200,000 tons of ethanolamine, and 150,000 tons of carbonates [2]. - The market share of ethanolamine and polyether monomers has steadily increased, with actual production ranking first and second nationally, respectively, both exceeding 20% market share [2]. - The company’s polyethylene and polystyrene products are tailored to market demands, with polyethylene recognized as an industry benchmark for stability and low impurity content, while polystyrene has improved toughness and high-temperature resistance, entering the core supply chain of major home appliance clients [2]. C3 Sector Development - The company has built the largest domestic and second-largest global production capacity for acrylic acid and esters [3]. - The new materials and new energy integrated project at the Pinghu base, with an annual production capacity of 800,000 tons of multi-carbon alcohol, successfully commenced operations, creating a closed-loop industrial chain with acrylic acid [3]. - The company has established the Satellite Global Company to accelerate overseas market expansion, with exports of acrylic acid and esters, polyether monomers, ethanolamine, and superabsorbent resins ranking among the top in China, collaborating with over 160 countries and regions [3].

Core Viewpoint - Renxin New Materials (301395.SZ) has completed the main construction and equipment installation for its "Huizhou Renxin New Materials Phase III Project," and is now ready for trial production [1] Group 1: Project Development - The project has received the approval from Huizhou Emergency Management Bureau for trial production [1] - The total registered production capacity for the company's polystyrene products will reach 480,000 tons per year, making it the largest in South China and the second largest nationwide [1] Group 2: Production Capacity - The company has an annual production capacity of 240,000 tons for general-purpose polystyrene (GPPS) and 240,000 tons for high-impact polystyrene (HIPS) [1]

Core Viewpoint - The company has completed the main construction and equipment installation for its "Huizhou Renxin New Materials Phase III Project" and is now ready for trial production, having received the necessary approval from the local emergency management bureau [1] Group 1: Project Development - The "Huizhou Renxin New Materials Phase III Project" has completed its main construction and equipment installation [1] - The project is now prepared for trial production following the receipt of the approval from the Huizhou Emergency Management Bureau [1] - Upon formal production, the company's total registered production capacity for polystyrene products will reach 480,000 tons per year [1]

Group 1: Company Overview - The company specializes in the research, production, and sales of polystyrene polymer new materials and is recognized as a national high-tech enterprise [1] - It is classified as a "Little Giant" enterprise by the Ministry of Industry and Information Technology [1] - Main products include GPPS (General Purpose Polystyrene) and HIPS (High Impact Polystyrene), widely used in various industries such as electronics, optical displays, toys, and medical devices [1] Group 2: Product Development and Sales - In 2024, HIPS product sales reached 93,190.28 tons, a 48.45% increase from 2023, driven by government policies promoting consumption and industrial upgrades [2] - The company plans to enhance the promotion of high-gloss HIPS materials and accelerate the introduction of low-temperature resistant HIPS materials in 2025 [2] - The sales volume of PS refrigerator transparent inner materials has steadily increased over the past three years [2] Group 3: Raw Materials and Procurement - The main raw material is styrene, procured primarily through long-term contracts, which helps reduce transportation costs and ensure material quality [2] - The company has a significant advantage in its procurement strategy due to its partnership with China National Offshore Oil Corporation [2] Group 4: Customer Structure and Revenue - In 2024, factory customers generated revenue of 89,502.44 million yuan, accounting for 40.51% of total revenue, with a growth of 5.44% compared to 2023 [3] - The increase in sales to factory customers, particularly from major clients like Midea, has contributed to the growth in this segment [3] Group 5: Strategic Projects - The company successfully acquired industrial land in the Daya Bay Petrochemical Zone for its integrated polystyrene new materials project, laying a solid foundation for future development [3] - The project aims to address raw material supply issues and enhance the company's competitiveness and profitability [3]

Core Viewpoint - Qingdao Guoen Technology Co., Ltd. has officially submitted its listing application to the Hong Kong Stock Exchange, marking a significant step in its capital market strategy and aiming to enhance its international influence and competitiveness [1] Group 1: Company Overview - Guoen Technology is a comprehensive enterprise group driven by technological innovation, focusing on long-term scale efficiency and implementing a "one body, two wings" development strategy in the large chemical and health industries [2] - In the large chemical sector, Guoen Technology is the second-largest organic polymer material modification producer in China and the largest producer of polystyrene, showcasing its strong market position [2] - In the health industry, Guoen Technology's subsidiary Dongbao Biological has established a comprehensive product layout from collagen to "collagen +", becoming a significant player in the health sector [3] Group 2: Financial Performance - The company has shown strong revenue growth, with total revenues of approximately RMB 134.06 billion, RMB 174.39 billion, and RMB 191.88 billion for the fiscal years 2022, 2023, and 2024, respectively [4] - The main revenue source is the large chemical sector, contributing RMB 183.3 billion in 2024, accounting for 95.6% of total revenue, while the health sector contributed RMB 8.53 billion, representing 4.4% of total revenue [5] - The overall gross profit margins for the fiscal years 2022, 2023, and 2024 were 11.8%, 9.2%, and 8.3%, respectively, with the health sector showing a higher margin of 23.2% in 2024 [6] Group 3: Future Prospects - The successful listing on the Hong Kong Stock Exchange is expected to provide new development opportunities for the company, allowing it to expand capacity, increase R&D investment, and enhance its domestic and international market presence [6] - The company's strong foundation in the large chemical and health sectors, along with its financial performance and future growth potential, positions it as a noteworthy investment opportunity [7]